Table 1.
Baseline characteristics of the 17 patients included in the present study.
| Variables | Patients with Good Outcome (n = 9) | Patients with Poor Outcome (n = 8) | p-Value |
|---|---|---|---|
| Median age, yrs (range) | 61 (47–74) | 68 (52–80) | ns |
| Gender Male Female |
7 2 |
6 2 |
ns |
| ECOG PS 0 1 |
5 4 |
3 5 |
ns |
| Hemoglobin < 10 gr/dL | 2 | 0 | ns |
| Liver metastases | 0 | 2 | ns |
| Number of poor prognostic factors 0 1 2 |
4 4 1 |
3 3 2 |
ns |
| Response to cis/gem CR PR SD |
4 4 1 |
1 6 1 |
ns |
| Status (at last visit) Alive Dead |
7 2 |
1 7 |
ECOG: Eastern Cooperative Oncology Group; PS: performance status; cis/gem: cisplatin/gemcitabine; CR: complete response; PR: partial response; SD: stable disease; ns: non-significance.